{"date":"2026-03-06","count":64,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6550-2026-03-06-2320-ht7qrm","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"23:20:06","subject":"代重要子公司霖揚生技製藥股份有限公司公告提報人力調整相關計畫","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-03-06 23:20，「代重要子公司霖揚生技製藥股份有限公司公告提報人力調整相關計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2026-03-06-1906-11vxjjv","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"19:06:31","subject":"本公司114年現金增資股款催繳公告","clause":"第9款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2026-03-06 19:06，「本公司114年現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-03-06-1903-1nyqnto","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"19:03:29","subject":"代子公司江蘇視准醫療器械有限公司公告董事會決議114年度股利分派事宜","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-03-06 19:03，「代子公司江蘇視准醫療器械有限公司公告董事會決議114年度股利分派事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-03-06-1859-1vhu1xi","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"18:59:07","subject":"公告本公司發言人異動","clause":"第8款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-03-06 18:59，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-03-06-1854-t77y4r","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"18:54:46","subject":"代重要子公司新普利股份有限公司公告董事會決議114年度盈餘分派","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-03-06 18:54，「代重要子公司新普利股份有限公司公告董事會決議114年度盈餘分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-03-06-1853-1mfc4ho","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"18:53:31","subject":"公告本公司除息基準日相關事宜","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-03-06 18:53，「公告本公司除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-03-06-1848-nob2a5","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"18:48:26","subject":"公告本公司董事會決議盈餘轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-03-06 18:48，「公告本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-03-06-1846-ueirm1","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"18:46:51","subject":"公告本公司董事會決議114年下半年度股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-03-06 18:46，「公告本公司董事會決議114年下半年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-03-06-1839-1ij5ajl","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"18:39:42","subject":"公告本公司董事會決議召開115年度股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-03-06 18:39，「公告本公司董事會決議召開115年度股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-03-06-1829-1hds7fq","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"18:29:07","subject":"公告本公司董事會通過114年第四季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-03-06 18:29，「公告本公司董事會通過114年第四季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-03-06-1802-11b1948","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"18:02:21","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第17款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-03-06 18:02，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-03-06-1801-19ws7nb","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"18:01:31","subject":"公告本公司除息基準日","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-03-06 18:01，「公告本公司除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-03-06-1800-11wjw0o","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"18:00:04","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-03-06 18:00，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-03-06-1758-gfep1d","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"17:58:59","subject":"公告本公司董事會通過114年第4季合併財務報告","clause":"第31款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-03-06 17:58，「公告本公司董事會通過114年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-03-06-1757-zvlmnp","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"17:57:30","subject":"公告本公司董事會解除經理人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-03-06 17:57，「公告本公司董事會解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-03-06-1756-1hz9x2g","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"17:56:49","subject":"公告本公司董事會決議114年度股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-03-06 17:56，「公告本公司董事會決議114年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2026-03-06-1755-1d29v9p","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"17:55:28","subject":"公告本公司變更股務代理機構事宜","clause":"第44款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2026-03-06 17:55，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-03-06-1754-5j9yh6","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"17:54:28","subject":"公告本公司董事會通過114年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-03-06 17:54，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-03-06-1754-11r8ft9","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"17:54:20","subject":"本公司董事會決議召開民國115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-03-06 17:54，「本公司董事會決議召開民國115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-03-06-1754-1q2r2w9","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"17:54:10","subject":"公告本公司董事會決議不分派114年度股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-03-06 17:54，「公告本公司董事會決議不分派114年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4173-2026-03-06-1753-1dd9qx8","company_id":"4173","company":"久裕","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"17:53:16","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：久裕（4173），2026-03-06 17:53，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-03-06-1751-1v52vy6","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"17:51:55","subject":"本公司董事會決議召開115年股東常會日期及開會議程相關事宜公告(調整召集事由順序)","clause":"第17款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-03-06 17:51，「本公司董事會決議召開115年股東常會日期及開會議程相關事宜公告(調整召集事由順序)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-03-06-1747-5j9yh6","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"17:47:37","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-03-06 17:47，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-03-06-1738-1dd9qx8","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"17:38:09","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"第17款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-03-06 17:38，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-03-06-1737-92x690","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"17:37:02","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-03-06 17:37，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2026-03-06-1735-5j9yh6","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"17:35:57","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2026-03-06 17:35，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-03-06-1734-92x690","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"17:34:32","subject":"董事會決議股利分派","clause":"第31款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-03-06 17:34，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-03-06-1733-1d29v9p","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"17:33:55","subject":"公告本公司變更股務代理機構事宜","clause":"第53款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-03-06 17:33，「公告本公司變更股務代理機構事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-03-06-1733-drgvb6","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"17:33:21","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-03-06 17:33，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-03-06-1732-1lacisf","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"17:32:08","subject":"公告本公司民國114年度財務報告業經董事會決議","clause":"第43款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-03-06 17:32，「公告本公司民國114年度財務報告業經董事會決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2026-03-06-1730-11b1948","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"17:30:15","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2026-03-06 17:30，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-03-06-1725-1jnb23l","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"17:25:54","subject":"代重要子公司佳醫資產管理事業股份有限公司公告董事會決議盈餘轉增資發行新股","clause":"第11款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-03-06 17:25，「代重要子公司佳醫資產管理事業股份有限公司公告董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-03-06-1724-1d99brs","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"17:24:59","subject":"代重要子公司佳醫資產管理事業股份有限公司公告董事會決議通過一一四年度盈餘分配案","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-03-06 17:24，「代重要子公司佳醫資產管理事業股份有限公司公告董事會決議通過一一四年度盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-03-06-1724-92x690","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"17:24:20","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-03-06 17:24，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-03-06-1723-5j9yh6","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"17:23:34","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第31款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-03-06 17:23，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-03-06-1722-10a2qxj","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"17:22:34","subject":"公告本公司董事會決議召開一一五年股東常會事宜","clause":"第17款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-03-06 17:22，「公告本公司董事會決議召開一一五年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-03-06-1642-uu70y4","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"16:42:37","subject":"公告本公司自主開發擁有全球開發權利的表觀遺傳免疫活化新藥GNTbm-38，已經完成中國NMPA的IND申請受理。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-03-06 16:42，「公告本公司自主開發擁有全球開發權利的表觀遺傳免疫活化新藥GNTbm-38，已經完成中國NMPA的IND申請受理。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-06-1639-15elaqu","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"16:39:23","subject":"本公司受邀參加摩根士丹利舉辦之英文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-06 16:39，「本公司受邀參加摩根士丹利舉辦之英文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-03-06-1639-d2pdg2","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"16:39:03","subject":"本公司受邀參加摩根士丹利舉辦之中文線上法人座談會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-03-06 16:39，「本公司受邀參加摩根士丹利舉辦之中文線上法人座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2026-03-06-1636-11wjw0o","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"16:36:23","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：德英（4911），2026-03-06 16:36，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2026-03-06-1627-17v5il9","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"16:27:52","subject":"公告本公司董事會決議114年度盈餘轉增資發行新股","clause":"第11款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：德英（4911），2026-03-06 16:27，「公告本公司董事會決議114年度盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2026-03-06-1623-1howjn","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"16:23:09","subject":"公告本公司董事會決議召開115年股東常會","clause":"第17款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：德英（4911），2026-03-06 16:23，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2026-03-06-1616-1b89la1","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"16:16:24","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：德英（4911），2026-03-06 16:16，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-03-06-1613-sybnzl","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"16:13:05","subject":"公告本公司董事會通過114年度自結財務資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-03-06 16:13，「公告本公司董事會通過114年度自結財務資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-03-06-1612-oydh5i","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"16:12:13","subject":"代子公司「蘇州中化藥品工業有限公司」公告總經理異動(姓名誤植更正)","clause":"第6款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-03-06 16:12，「代子公司「蘇州中化藥品工業有限公司」公告總經理異動(姓名誤植更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-03-06-1609-hurcou","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"16:09:33","subject":"本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-03-06 16:09，「本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-03-06-1603-54swv6","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"16:03:58","subject":"公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-03-06 16:03，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-03-06-1548-3ryoc9","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"15:48:16","subject":"本公司董事會通過更換主辦輔導推薦證券商案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-03-06 15:48，「本公司董事會通過更換主辦輔導推薦證券商案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-03-06-1536-92x690","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"15:36:12","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-03-06 15:36，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-03-06-1535-1wm4jkt","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"15:35:46","subject":"公告本公司115年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽由特定人認購事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-03-06 15:35，「公告本公司115年第一次現金增資全體董事放棄認購股數達得認購股數二分之一以上，並洽由特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-03-06-1525-1d89cmx","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"15:25:32","subject":"公告本公司以及母公司廣泰金屬工業(股)公司資訊系統遭受駭客網路攻擊。","clause":"第26款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-03-06 15:25，「公告本公司以及母公司廣泰金屬工業(股)公司資訊系統遭受駭客網路攻擊。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-03-06-1437-d0w0dp","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"14:37:19","subject":"公告本公司受邀參加中信證券舉辦之投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-03-06 14:37，「公告本公司受邀參加中信證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-06-1432-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"14:32:55","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-06 14:32，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-03-06-1432-1mrnrt5","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"14:32:32","subject":"代重要子公司優良生技醫藥股份有限公司公告董事會決議召開115年度股東常會","clause":"第17款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-03-06 14:32，「代重要子公司優良生技醫藥股份有限公司公告董事會決議召開115年度股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-03-06-1432-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"14:32:28","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-03-06 14:32，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-03-06-1431-109dstv","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"14:31:05","subject":"代重要子公司優良生技醫藥股份有限公司公告董事會決議不分派股利","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-03-06 14:31，「代重要子公司優良生技醫藥股份有限公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-03-06-1416-1rq14zm","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"14:16:35","subject":"公告本公司收到「KETAMINE PAMOATE AND USE THEREOF」祕魯專利核准通知書。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-03-06 14:16，「公告本公司收到「KETAMINE PAMOATE AND USE THEREOF」祕魯專利核准通知書。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-03-06-1358-dgpq5s","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"13:58:43","subject":"公告本公司發言人、財務主管、會計主管暨公司治理主管異動","clause":"第8款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-03-06 13:58，「公告本公司發言人、財務主管、會計主管暨公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2026-03-06-1358-s364tb","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"13:58:24","subject":"公告本公司訂定除息基準日","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2026-03-06 13:58，「公告本公司訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2026-03-06-1346-17kqo1x","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"13:46:57","subject":"商之器董事會決議股利分派","clause":"第14款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2026-03-06 13:46，「商之器董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2026-03-06-1346-123a5qa","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"13:46:33","subject":"公告本公司經董事會決議之114年度合併財務報告","clause":"第31款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2026-03-06 13:46，「公告本公司經董事會決議之114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2026-03-06-1344-nvtqrg","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2026-03-06","time":"13:44:58","subject":"商之器董事會決議召開115年股東常會公告","clause":"第17款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2026-03-06 13:44，「商之器董事會決議召開115年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-03-06-1001-1fqkmsr","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-03-06","time":"10:01:33","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-03-06 10:01，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6483-2026-03-06-0105-3j6fdm","company_id":"6483","company":"原創生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-06","time":"01:05:49","subject":"公告本公司「具格蘭氏陰性菌抗菌活性之螯合型複合微胞及其用途」取得中華民國經濟部智慧財產局專利核准審定書","clause":"第44款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：原創生醫（6483），2026-03-06 01:05，「公告本公司「具格蘭氏陰性菌抗菌活性之螯合型複合微胞及其用途」取得中華民國經濟部智慧財產局專利核准審定書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}